WPI 3 Pill - white round, 8mm
Pill with imprint WPI 3 is White, Round and has been identified as Paliperidone Extended-Release 3 mg. It is supplied by Actavis Pharma, Inc.
Paliperidone is used in the treatment of Schizoaffective Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3
Paliperidone Extended-Release
- Imprint
- WPI 3
- Strength
- 3 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3693 (Discontinued)
- Inactive Ingredients
-
ammonia,
butylated hydroxytoluene,
cellulose acetate,
silicon dioxide,
FD&C Red No. 40,
aluminum oxide,
hydroxypropyl cellulose,
hypromelloses,
ferrosoferric oxide,
polyethylene glycol,
povidone,
propylene glycol,
sodium chloride,
stearic acid,
titanium dioxide,
lactose monohydrate,
triacetin
Note: Inactive ingredients may vary.
Related images for "WPI 3"
More about paliperidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (650)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Paliperidone drug information
- Paliperidone injection
- Paliperidone (Intramuscular) (Advanced Reading)
- Paliperidone (Oral) (Advanced Reading)
- Paliperidone Extended-Release Tablets
Other brands
Invega, Invega Sustenna, Invega Trinza, Invega Hafyera, Erzofri
Professional resources
Other brands
Invega, Invega Sustenna, Invega Trinza, Invega Hafyera, Erzofri
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.